Goin Kathleen: insider trades.
Goin Kathleen reported 18 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($2.0M), across 1 company.
- Transactions
- 18
- Purchases (P)
- 0
- Sales (S)
- 12
- Companies
- 1
- Name as filed
- Goin Kathleen
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | Officer · Chief Operating Officer | 18 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Palvella Therapeutics, Inc. | S | 1,654 | $153.24 | 0 | Form 4 |
| 2026-09-16 | Palvella Therapeutics, Inc. | S | 989 | $152.36 | 1,654 | Form 4 |
| 2026-09-16 | Palvella Therapeutics, Inc. | S | 1,659 | $151.16 | 2,643 | Form 4 |
| 2026-09-16 | Palvella Therapeutics, Inc. | M | 2,154 | $7.14 | 2,154 | Form 4 |
| 2026-09-16 | Palvella Therapeutics, Inc. | M | 2,148 | $9.08 | 4,302 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | S | 102 | $155.59 | 302 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | S | 400 | $153 | 404 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | S | 1,998 | $151.8 | 804 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | S | 1,500 | $151.39 | 2,802 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | M | 2,148 | $9.08 | 4,302 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | M | 2,154 | $7.14 | 2,154 | Form 4 |
| 2026-08-19 | Palvella Therapeutics, Inc. | S | 302 | $156.77 | 0 | Form 4 |
| 2026-07-15 | Palvella Therapeutics, Inc. | S | 1,911 | $150.25 | 0 | Form 4 |
| 2026-07-15 | Palvella Therapeutics, Inc. | S | 1,029 | $149.27 | 1,911 | Form 4 |
| 2026-07-15 | Palvella Therapeutics, Inc. | S | 840 | $148.4 | 2,940 | Form 4 |
| 2026-07-15 | Palvella Therapeutics, Inc. | S | 522 | $147.14 | 3,780 | Form 4 |
| 2026-07-15 | Palvella Therapeutics, Inc. | M | 2,148 | $9.08 | 4,302 | Form 4 |
| 2026-07-15 | Palvella Therapeutics, Inc. | M | 2,154 | $7.14 | 2,154 | Form 4 |
Questions
What stock did Goin Kathleen buy or sell?
Goin Kathleen reported 18 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 12 sales ($2.0M), across 1 company.
Is Goin Kathleen the same person as other filers with this name?
This page covers SEC CIK 1912570 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/goin-kathleen-1912570.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.